Sponsor:
Stanford University
Code:
NCT05088356
Conditions
Allogeneic Hematopoietic Cell Transplantation (HCT)
Advanced Hematologic Malignancies
Acute Leukemia
Chronic Myelogenous Leukemia
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Purified regulatory T-cells (Treg) plus CD34+ HSPC
Fludarabine
Melphalan
CliniMACS CD34 Reagent System
Tacrolimus
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Stanford University on 2024-02-20.